Physician profile
Christopher M Prior
NPI 1487670717
$2,639.78
in general payments reported to CMS, 2019-2025
24 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $264 · 2021: $480 · 2022: $568 · 2023: $625 · 2024: $383 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,131 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.27 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $518.75 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $427.30 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $235.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $208.68 | 2019-2024 | Prolia, Evenity, Otezla |
| Lilly USA, LLC | $193.84 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $188.34 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $181.30 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $146.99 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.33 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.15 | 2022-2024 | Trintellix |
| Merck Sharp & Dohme LLC | $48.85 | 2023 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $42.09 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $41.07 | 2022-2023 | Eliquis |
| Organon LLC | $38.03 | 2021-2022 | |
| Pfizer INC. | $37.33 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $30.56 | 2023-2024 | Cologuard Collection Kit |
| Eisai INC. | $29.41 | 2020-2022 | |
| Medtronic, INC. | $22.52 | 2024 | Minimed 780g |
| Neurocrine Biosciences, INC. | $15.84 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.68 | 2021 | |
| Sobi, INC | $15.58 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.33 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.71 | 2022 | |
| Corium, LLC | $10.47 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Prior listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.